OrthoSpineNews

APRIL 1, 2025

Our goal is to move spine surgery beyond the limits of legacy systems, reimagining treatment processes to make them safer, more efficient, and more effective for every patient. This seamless integration is intended to provide a personalized and effective approach to spine surgery, which enhances patient care and surgical efficiency.

Degenerative Disc Disease

OrthoSpineNews

JUNE 23, 2025

Food and Drug Administration (FDA) premarket approval (PMA) of PearlMatrix P-15 Peptide Enhanced Bone Graft as a Class III drug-device combination product for use in single-level transforaminal lumbar interbody fusion (TLIF) surgery in adult patients with degenerative disc disease (DDD).

Degenerative Disc Disease

OrthoSpineNews

JULY 8, 2025

AdventHealth Avista, an Orthopedic and Spine Center of Excellence, conducted the first lumbar fusion procedure with PearlMatrix Bone Graft, the first and only bone growth accelerator for lumbar fusion. The first post-approval procedure on an adult patient with degenerative disc disease (DDD) was performed by neurosurgeon Sharad Rajpal, M.D.,

Degenerative Disc Disease

ChiroJunky

JANUARY 1, 2023

Wellness, alignment, and holistic were trend words in 2022, but chiropractic was largely missing from the thread. Same Spine Every December 31st as the year turns another age, your spine also grow older. Though some organs tissues have the ability to regenerate, like the liver, the spine ages and degenerates overtime.

Spine

ChiroJunky

JANUARY 1, 2023

Wellness, alignment, and holistic were trend words in 2022, but chiropractic was largely missing from the thread. Same Spine Every December 31st as the year turns another age, your spine also grow older. Though some organs tissues have the ability to regenerate, like the liver, the spine ages and degenerates overtime.

Spine

OrthoSpineNews

FEBRUARY 10, 2025

Precision Spine Inc., million Market structure Fragmented YoY growth 2022-2023 (%) 5.0 Precision Spine Inc., Market Driver Minimally invasive spine surgery (MISS) utilizes smaller, specialized implants to minimize tissue damage, blood loss, and infection risk. Key market players include B.Braun SE, Globus Medical Inc.,

Degenerative Disc Disease